tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

BioMarin raises FY25 adjusted EPS view to $4.40-$4.55 from $4.20-$4.40

FY25 consensus $4.16. Narrows FY25 revenue view to $3.125B-$3.2B from $3.1B-$3.2B, consensus $3.14B.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1